Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SBTX - Silverback Therapeutics Inc

Previous close
6.06
0   0%

Share volume: 0
Last Updated: Wed 09 Nov 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$6.06
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
57%
Profitability 68%
Dept financing 0%
Liquidity 0%
Performance 75%
Performance
5 Days
-4.55%
1 Month
11.81%
3 Months
17.87%
6 Months
94.37%
1 Year
-33.30%
2 Year
-76.52%
Key data
Stock price
$6.06
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.80 - $8.97
52 WEEK CHANGE
-$0.30
MARKET CAP 
211.662 M
YIELD 
N/A
SHARES OUTSTANDING 
36.058 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.02
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$151,669
AVERAGE 30 VOLUME 
$191,659
Company detail
CEO:
Region: US
Website: silverbacktx.com
Employees: 54
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.

Recent news